United States: FDA to phase out synthetic food dyes - What does this mean for the industry?

In brief

On April 22, 2025, the US Department of Health and Human Services (HHS) and US Food and Drug Administration (FDA) announced their plan to phase out all petroleum-based synthetic dyes from the US food supply by the end of 20261. This initiative is part of a broader effort to promote a healthier America, driven by concerns over the alleged health impacts of synthetic food dyes, particularly on children's behavior. To support this transition, FDA is encouraging food companies to replace synthetic dyes with natural ingredients. Under the proposed phase-out plan, food companies will have less than two years to switch from certain synthetic dyes to natural alternatives. The FDA has indicated that it will provide guidance and offer regulatory flexibilities to help industries adapt to these changes.


Contents

What does this mean for the industry? As discussed in more detail below, it is important to note that the announced plan only pertains to the use of synthetic dyes in food applications, not in drugs or other regulated uses. Clarification is needed on whether the proposed end-of-2026 timeline is intended as the compliance date for stopping the manufacture of foods containing these synthetic dyes, or if it allows for food products containing these dyes to work their way through distribution even after 2026. Additionally, the industry should begin evaluating whether existing natural ingredients can effectively replace synthetic dyes during the proposed transition period and consider whether new color additive petitions should be submitted to FDA.

Key takeaways

  • Firms that use petroleum-based synthetic dyes should review their formulations and business operations with suppliers to determine the feasibility of transition and availability of natural alternatives, and also consider whether new color additive petitions should be submitted to FDA.
  • Firms should closely monitor FDA's upcoming guidance on the phase-out plan, including the specific compliance deadline to remove the synthetic dyes, updates food labeling, and guidance for products that were manufactured.

Firms may consider engaging with the FDA and HHS to seek clarifications regarding the transition period. This can be effectively done through trade associations or industry groups, allowing them to collectively advocate for their interests and obtain clarity from the agency on the transition process.

In depth

We are highlighting a few FDA key actions below, along with our quick observations:

  • Revoking authorization for two food colorings. Within the coming months, FDA will revoke authorization for two synthetic food colorings — Orange B and Citrus Red No. 2. We would like to note that FDA's current regulations narrowly permit the use of Orange B in coloring the casings or surfaces of frankfurters and sausages, and the use of Citrus Red No. 2 only for coloring the skins of oranges that are not intended or used for processing2. Given the limited applications of these two synthetic food colorings, the transition to natural alternatives might be somewhat easier compared to other synthetic dyes.
  • Eliminating six synthetic dyes in food uses only. By the end of 2026, FDA will work with the industry to eliminate six remaining synthetic dyes from the food supply — FD&C Green No. 3, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6, FD&C Blue No. 1, and FD&C Blue No. 2. Importantly, while some of the listed dyes are authorized for use in multiple FDA-regulated products, the phase-out plan only focuses on their application in food. For example, FDA's current regulations authorize the use of FD&C Yellow No. 5 in foods and drugs, and the use of FD&C Blue No. 2 in foods and medical devices3. Apparently, the FDA phase-out plan would not impact their use in non-food products at the moment.
  • Authorizing new natural color additives. FDA is fast-tracking the review of four new natural color additives—calcium phosphate, Galdieria extract blue, gardenia blue, butterfly pea flower extract, and also accelerating the review and approval of other natural alternatives to synthetic food dyes. Please note that the colors of the four new natural additives are white, blue, and purple, which do not fully match the colors of the synthetic dyes being phased out. Additionally, a quick review of the food color additive petitions filed by the relevant parties indicates that these natural additives do not have the same types of applications as the synthetic dyes being phased out.
  • Expediting the deadline to remove FD&C Red No. 3. In January 2025, FDA issued a new rule revoking authorization for use of FD&C Red No. 3 in food and ingested drugs. The rule also mandated that manufacturers who use FD&C Red No. 3 in food and ingested drugs will have until January 15, 2027, or January 18, 2028, respectively, to reformulate their products. The phase-out plan now requests that food companies (again, only concerning food applications) remove Red No. 3 sooner than the previously required deadline. However, it remains unclear whether the new deadline means that manufacturers may not use FD&C Red No. 3 in food manufacturing, or more broadly, food products being sold in the marketplace should not contain FD&C Red No. 3 as of the expedited compliance date.

1 https://www.fda.gov/news-events/press-announcements/hhs-fda-phase-out-petroleum-based-synthetic-dyes-nations-food-supply
2 See 21 CFR §§ 74.250, 74.302.
3 See 21 CFR §§ 74.705, 21 CFR 74.1705, 74.102, 74.3102.

 


Contact Information

Copyright © 2025 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.